Checked.be
Active
BE 0424.574.344Private limited company
INTERMEDI
Booiebos 6A ·9031 Gent, Belgium· 42 yrs active
Sector: Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
(47741)
Conclusion
INTERMEDI has been active since 1983 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €940k and a net result of €75k. Its solvency ranks better than 89% of 9575 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.6% (low).
Based on the State Gazette, CBE and 2 annual accounts.
Key figures
| Equity | €940k |
| Net result | €75k |
| Staff (FTE) | 9.6 |
| Better than sector | 89% |
Financial profile
82
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
94
Profitability
40
Solvency
100
Growth
78
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Long-established
Founded in 1983, 42 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
94
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€90k
estimate, not credit advice
Score history
68
2023
94
2024
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 5.31 (≥ 1.5)
+10
Quick ratio
Quick ratio 3.89 (≥ 1.0)
+5
Leverage
Debt/equity 0.25 (< 1.0)
+10
Profitability
ROE 8%
+3
Interest coverage
Interest coverage 26.6× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Financial overview
Annual accounts filed on 13-06-2025 with the NBB · fiscal year 2024 · abbreviated schema
Sector comparison
Fiscal year 2024 · NACE 47, Retail trade · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 79.9% | 38.6% | |
| Net result | €75k | €44k | |
| Equity | €940k | €332k | |
| Gross operating margin | €628k | €266k | |
| Staff costs | €527k | €166k |
€91k
-
23-24
€75k
+984.3%
23-24
€83k
+368.1%
23-24
€1.18M
+4.3%
23-24
€940k
+1.1%
23-24
€921k
+1.2%
23-24
10
+6.7%
23-24
€527k
-2.6%
23-24
€24k
+1676.4%
23-24
€65k
-19.9%
23-24
€236k
+18.7%
23-24
€214k
+7.4%
23-24
€22k
-
23-24
5.31
-4.8%
23-24
3.89
-4.4%
23-24
79.9%
-3.0%
23-24
0.25
+17.4%
23-24
8.0%
+972.0%
23-24
6.4%
+940.1%
23-24
26.58
+3498.0%
23-24
Figures by fiscal year and ratios
Change versus the prior fiscal year, coloured by direction (green = favourable).
| Fiscal year | 2024 Δ | 2023 Δ |
|---|---|---|
| Deposit | abbreviated schema | abbreviated schema |
| Revenue | - | - |
| EBITDA | - | - |
| Net profit | +984.3% | - |
| Cash flow | +368.1% | - |
| Staff costs | -2.6% | - |
| Income taxes | +1676.4% | - |
| Dividends | -19.9% | - |
| Total assets | +4.3% | - |
| Equity | +1.1% | - |
| Debt | +18.7% | - |
| of which ≤ 1y | +7.4% | - |
| of which > 1y | - | - |
| Working capital | +1.2% | - |
| Employees (FTE) | +6.7% | - |
Ratios (computed)
| 2024 | 2023 | |
|---|---|---|
| Current ratio | 5.31 | 5.57 |
| Quick ratio | 3.89 | 4.07 |
| Working capital ratio | 78.3% | 80.7% |
| Solvency | 79.9% | 82.3% |
| Debt / equity | 0.25 | 0.21 |
| Long-term debt ratio | 0.02 | - |
| Interest coverage | 26.58 | 0.74 |
| Gross margin | - | - |
| Net margin | - | - |
| ROA | 6.4% | 0.6% |
| ROE | 8.0% | 0.7% |
| EBITDA margin | - | - |
| Days sales outstanding | - | - |
| Days payable outstanding | - | - |
| Inventory turnover | - | - |
| Days inventory (DSI) | - | - |
Balance-sheet composition 2024
Full annual accounts (26 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 | 2023 |
|---|---|---|---|
| Balance sheet, Assets | |||
| TOTAL ASSETS | 20/58 | €1.18M | €1.13M |
| Fixed assets | 21/28 | €41k | €19k |
| Tangible fixed assets | 22/27 | €41k | €18k |
| Financial fixed assets | 28 | €424 | €424 |
| Current assets | 29/58 | €1.14M | €1.11M |
| Stocks & contracts in progress | 3 | €303k | €300k |
| Amounts receivable within one year | 40/41 | €153k | €105k |
| Investments | 50/53 | €303k | €427k |
| Cash & bank | 54/58 | €349k | €251k |
| Balance sheet, Equity & liabilities | |||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.18M | €1.13M |
| Equity | 10/15 | €940k | €929k |
| Contributions / capital | 10/11 | €9k | €9k |
| Reserves | 13 | €874k | €864k |
| Accumulated profits (losses) | 14 | €57k | €57k |
| Amounts payable | 17/49 | €236k | €199k |
| Amounts payable after one year | 17 | €22k | - |
| Amounts payable within one year | 42/48 | €214k | €199k |
| Trade debts payable within one year | 44 | €8k | €10k |
| Income statement | |||
| Gross operating margin | 9900 | €628k | €530k |
| Operating result | 9901 | €83k | €-29k |
| Financial income | 75 | €19k | €13k |
| Financial charges | 65 | €3k | €-24k |
| Result before taxes | 9903 | €99k | €8k |
| Income taxes | 67/77 | €24k | €1k |
| Net result for the period | 9904 | €75k | €7k |
| Result to be appropriated | 9905 | €75k | €7k |
Legal Structure
| NACE primary | Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses(47741) |
| Legal form | Private limited company(610) |
| Incorporation | 27-09-1983 |
| Status | Active |
| Postal code | 9031 |
Establishment units
INTERMEDI
since 19832.022.905.405
INTERMEDI
since 19832.230.643.177
Real-estate footprint
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34013A1207/00G007 | Flanders | 5,165 m² | 1 · 2,147 m² | - |
| 44017D0822/00A002 | Flanders | 2,807 m² | 1 · 2,280 m² | 45.5 m · 2 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
2025
13-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
19-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
21-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
23-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
25-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
27-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
27-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
27-07
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
NBB filing
Belgian State Gazette reading coverage
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Wholesale of pharmaceutical and medical goods46460Retail trade47740Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses4774152320
Names & trade names
| Legal nameNL | INTERMEDI |
Similar companies
CEDEK MEDICAL
BE 0443.485.087 · Liège
Audika
BE 0673.554.043 · Leuven
OPHTALMO SURGICAL
BE 0642.908.278 · Oudenaarde
DE KNOP C & N
BE 0875.956.916 · Halle
PRIMROSE FARMA BELGICA
BE 0827.760.980 · Torhout